Pradip Devhare

ICMR-National Institute of Virology — India

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index1.0kcitations51works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(15), Cancer Cells and Metastasis(12), Hepatitis Viruses Studies and Epidemiology(9), Hepatitis C virus research(6), Hepatitis B Virus Studies(5)

Publications51 total

Evaluation and Immunogenicity of Combined Liposome-Based Vaccine Candidates against Hepatitis E and B Viruses in Rhesus Monkeys
Vaccines·2024Open Access
Addendum: Liquid biopsy and multi-analyte testing guided treatment of <i>HER2</i> positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy
Oncotarget·2022Open Access
Re-establishing Responsiveness in a Case of Refractory Metastatic Rectal Cancer with a Personalized de novo Combination Regimen
American journal of cancer case reports·2021
Interplay between Hepatitis E Virus and Host Cell Pattern Recognition Receptors
International Journal of Molecular Sciences·2021· 15 citedOpen Access
Abstract PS3-13: Non-invasive screening for breast cancer risk based on circulating ensembles of tumor associated cells
Cancer Research·2021
Development and validation of a multigene variant profiling assay to guide targeted and immuno therapy selection in solid tumors
PLoS ONE·2021· 1 citedOpen Access
OFP01.05 Circulating Ensembles of Tumor Associated Cells Facilitate Efficient Triaging of Asymptomatic Individuals for Low Dose Computed Tomography
Journal of Thoracic Oncology·2021
PR01.01 Evaluation of Circulating Tumor Cells for Non-Invasively Discerning Lung Primary from Metastasis
Journal of Thoracic Oncology·2021Open Access
Liquid biopsy and multi-analyte testing guided treatment of <i>HER2</i> positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy
Oncotarget·2020· 5 citedOpen Access
73P Anti-angiokinases in patient-specific combination regimens can improve outcomes in advanced metastatic cancers
Annals of Oncology·2020
47P Improved treatment outcomes by using patient-specific drug combinations in mTOR activated advanced metastatic cancers
Annals of Oncology·2020
Management of a Refractory EIF3E-RSPO2 Fusion Positive Pilomatrical Cancer Patient with Encyclopedic Tumor Analysis Guided Treatment
Acta Scientific Cancer Biology·2020Open Access
Long Overall Survival in a Case of Refractory Stage IV Squamous Cell Carcinoma of Lung Treated with Personalized De Novo Combination Regimen
Clinical Case Reports International·2020Open Access
Abstract A49: Viable circulating ensembles of tumor-associated cells persist in pretreated patients with solid organ cancers showing no radiologically detectable disease
Clinical Cancer Research·2020
Abstract B17: An mRNA signature that accurately discerns gliomas from healthy individuals
Clinical Cancer Research·2020
Abstract B16: Noninvasive liquid biopsies for guideline-compliant diagnostic assessment in ovarian cancers
Clinical Cancer Research·2020
Abstract B15: Circulating tumor cells express tissue specific antigens in multiple cancers
Clinical Cancer Research·2020
Circulating microtumors: A functional hallmark for cancer detection and management.
Journal of Clinical Oncology·2020
Multi-analyte interrogation based treatment of advanced refractory cancers.
Journal of Clinical Oncology·2020
Multi-analyte liquid biopsies based treatment in advanced refractory cancers.
Journal of Clinical Oncology·2020· 2 cited
page 1 of 3Next →

Frequent Co-authors

Dadasaheb Akolkar(31), Pooja Fulmali(30), Rajan Datar(29), Ajay Srinivasan(28), Darshana Patil(23), Vineet Datta(21), Sachin Apurwa(20), Navin Srivastava(17), Revati Patil(15), Sanket Patil(14), Ratna B. Ray(11), Cynthe Sims(11), Shoeb Patel(10), Sewanti Limaye(9), Timothy Crook(8), Jinumary John(8), Kavita S. Lole(7), Ashwini Ghaisas(7), Raja Dhasarathan(7), Rohit Chougule(6)